Resources
Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease
Part I:
Fundamentals
Chapter 1 Tables
Human Genome Epidemiology: Scope and Strategies
Muin J. Khoury, Julian Little, Wylie Burke
Table 1-1
Selected Web-based News Stories Headlines Reporting on Association of Genes With Various Health Outcomes
| Headline | Source | Date |
|---|---|---|
| Gene may trigger idiopathic epilepsy | Health News UK | March 2003 |
| Flesh eating disease linked to gene differences | New Scientist | November, 2002 |
| Genetic variant may impact smoking cessation | EurekAlert | November, 2002 |
| Genes influence heart disease risk from fatty diet | Reuter’s Health | October, 2002 |
| Two genes linked to congestive heart failure | New York Times | October, 2002 |
| Genes may play a role in carpal tunnel syndrome | Reuter’s Health | July 2002 |
| Gene implicated in stress-alcohol connection | Reuter’s Health | May 2002 |
| Genetic variants put some patients at risk for particular drug reactions | ScienceDaily | April 2002 |
| Osteoarthritis gene breakthrough | BBC News | April 2002 |
Source: Office of Genomics and Disease Prevention. Genomics Weekly Update, http://www.cdc.gov/genomics/update/current.htm
Table 1-2
Vision of Genomic Medicine in the Year 2010: Results of Genetic Testing in a Hypothetical Patient
| Condition | Genes | Relative Risk | Lifetime Risk (%) |
|---|---|---|---|
| Prostate cancer | HPC1, 2 and 3 | 0.4 | 7 |
| Alzheimer disease | APOE, FAD3, XAD | 0.3 | 10 |
| Coronary artery disease | APOB, CETP | 2.5 | 70 |
| Colon cancer | FCC4, APC | 4.0 | 23 |
| Lung cancer | NAT2 | 6.0 | 40 |
Source: Adapted from Collins (12)
Table 1-3
From Gene Discovery to Applications: Examples of the Role of the Public Health Sciences
| Field | Question |
|---|---|
| Epidemiology | What are the risks? |
| Policy | What is the value-added of using genetic information to target interventions? (e.g., don’t we want every one to stop smoking?) |
| Communication | What is the best way to communicate risk information? |
| Economics | Is it cost-effective to do genetic testing? |
| Outcomes research | How do we measure the impact of genetic information on health, personal and social outcomes? |
Table 1-4
From Gene Discovery to Applications: The Continuum of Human Genome Epidemiology
| Field | Application | Types of Studies |
|---|---|---|
| Genetic epidemiology | Gene discovery | linkage analysis, family-based association studies |
| Molecular epidemiology | Gene characterization | population studies to characterize gene prevalence, gene-disease associations, and gene-gene and gene-environment interaction |
| Applied epidemiology/ Heath services research | Evaluating health impact | Studies to evaluate validity and utility of genetic information in clinical trials or observational clinical settings (clinical epidemiology) or population setting (public health epidemiology) |
Table 1-5
Types and Examples of Human Genome Epidemiology Studies
| Type of Study | Study Designs | Examples |
|---|---|---|
| Gene discovery | Linkage analysis methods | Body mass index(53) Attention deficit disorder(54) Type 2 diabetes (55) Celiac disease (56) |
| Gene characterization | Population prevalence | Prevalence of HFE mutations in the United States (57) |
| Genotype-disease associations | Transforming growth factor beta-diabetic retinopathy (58) | |
| Gene-gene and gene- environment interaction | Multiple gene polymorphisms and dietary interactions in colorectal adenoma (59) | |
| Application of genetic information | Evaluating validity & utility of genetic tests for clinical use | Assessment of interleukin-1 genotype testing for chronic periodontitis (60) |
| Characteristics of individuals tested for BRCA1/2 (61) | ||
| Evaluating utility of genetic tests for population screening | Assessment of testing for HFE mutations in population screening for iron overload(62) |
Table 1-6
Role of Epidemiology in the Study of Human Diseases in Relation to Paradigm Shifts in Biology and Medicine
| 20th Century | 21st Century | Role of Epidemiology |
|---|---|---|
| Genetic Diseases | All Diseases | Will use genetic variants routinely in the study of gene-environment in disease |
| Genomics | Proteomics | Will use biological markers of exposure, susceptibility and outcomes |
| Gene mapping | Gene sequencing + variant discovery | Will evaluate allelic variants in relation to health outcomes |
| One gene | Multiple genes | Will assess complex genotypes |
| Gene action | Gene regulation | Will evaluate structural and regulatory genes as disease risk factors |
| Diagnostic testing | Susceptibility testing | Will provide a basis for assessing clinical validity of genetic tests for disease susceptibility |
Source: Adapted from Peltonen and McKusick (33)
Contact Us:
- CDC-INFO Contact Center
Phone: 800-232-4636 (800-CDC-INFO)
Hearing Impaired: 888-232-6348 - cdcinfo@cdc.gov
- Additional information for Public Health Genomics is available on our contact page.


